Oluwatosin Smith

2 months ago | ophthalmologytimes.com | Oluwatosin Smith |Sheryl Stevenson |Hattie Hayes

Oluwatosin U. Smith, from Glaucoma Associates of Texas in Dallas, moderated the Glaukomtecken session during the American Society of Cataract and Refractive Surgery's Glaucoma Day on April 25, held in Los Angeles, California. In an interview with the Eye Care Network, Smith highlighted key takeaways from the session. "In glaucoma, we have lots of new options when it comes to not just glaucoma treatment, but also technology that helps us to better take care of our patients," she said.

2 months ago | ophthalmologytimes.com | Sheryl Stevenson |Peter McDonnell |Nicole Bajic |John Berdahl |David Eichenbaum |Ehsan Sadri | +2 more

Half a decade after COVID-19 reshaped the landscape of health care, ophthalmology practices are still adapting—not out of crisis, but through continuous innovation and resilience. A key consideration now is which adaptations have endured, and which have been left behind. Understanding how patient behavior and expectations have shifted in this post-COVID landscape remains essential, prompting ongoing refinements in care delivery and operational strategy.

2 months ago | ophthalmologytimes.com | Sheryl Stevenson |Peter McDonnell |Nicole Bajic |John Berdahl |David Eichenbaum |Ehsan Sadri | +2 more

Five years ago, in April 2020, ophthalmologists across the country were navigating shuttered offices, improvised personal protective equipment (PPE), and a cascade of unknowns. Just weeks earlier, the World Health Organization had declared COVID-19 a global pandemic—setting in motion a series of events that would redefine clinical care. Now, in April 2025, we mark 5 years since that turning point—not just to remember the disruption, but to reflect on the transformation.

2 months ago | eyetube.net | Arsham Sheybani |Oluwatosin Smith

Ab Externo Xen Gel Stent Implantation Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Oluwatosin U. Smith, MD Show Description + Oluwatosin Smith, MD, sits down with Iqbal Ike K. Ahmed, MD, FRCSC, and Arsham Sheybani, MD, to discuss the evolution of Xen Gel Stent (AbbVie) usage over time and the cases in which she uses the MIGS device. She reviews the differences in her approach for adult and pediatric patient populations and comments on maximizing outcomes with an ab externo technique.